[Other] In HIV-1, bictegravir–lenacapavir was noninferior to continued complex regimens for maintaining viral suppression at 48 wk |
|
This post will be closed automatically in 2026-09-19 22:15
Reward10points
|
post
reply
points
10
10
Application of User-Centered Design Methodology for Human Digital Twins
10
https://link.springer.com/protocol/10.1007/978-1-0716-0920-0_1
20
Risk Stratification for Breast Cancer Screening:AJRExpert Panel Narrative Review
30
Software engineering — Software product Quality Requirements and Evaluation (SQuaRE) — Data quality model
20
The Role of IR in Pediatric Liver Cancer
